Moderna, Inc. (MRNA) 今日盘中大涨5.01%，引起了市场的广泛关注。
消息面上，Moderna宣布获得全球联盟流行病防备创新联盟（CEPI）高达5430万美元的资助，用于支持其实验性禽流感疫苗mRNA-1018的后期开发。该疫苗是基于mRNA技术的首个进入关键试验阶段的禽流感疫苗，具有开创性意义。
Moderna表示，该项目是其在大流行威胁出现后100天内开发疫苗的广泛努力的一部分。作为协议的一部分，Moderna将为中低收入国家保留20%的生产能力，并承诺在大流行期间以低廉的价格供应疫苗。这一消息增强了市场对Moderna技术实力和社会责任感的信心，推动了股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.